TaiMed Biologics Inc. (TPEX:4147)
Taiwan · Delayed Price · Currency is TWD 55.00
-0.10 (-0.18%)
Nov 6, 2026, 1:30 PM CST
TaiMed Biologics Market Cap
TaiMed Biologics has a market cap or net worth of 15.03 billion as of November 6, 2026. It is the 14,854th most valuable company in the world and the 483rd biggest in Taiwan. Its market cap has decreased by 20.40% in one year.
Market Cap
15.03B
Enterprise Value
13.90B
Revenue
619.49M
Global Rank
Country Rank
#483 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 15.03B, an increase of 482.31%. That is a compound annual growth rate of 11.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 15.03B | -10.13% |
| Dec 31, 2025 | 16.72B | -28.81% |
| Dec 31, 2024 | 23.48B | 13.20% |
| Dec 29, 2023 | 20.75B | 16.27% |
| Dec 30, 2022 | 17.84B | 0.17% |
| Dec 30, 2021 | 17.81B | -16.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 21.55B |
| Sunmax Biotechnology | 21.27B |
| CHO Pharma | 16.11B |
| Medigen Vaccine Biologics | 15.42B |
| Steminent Biotherapeutics | 15.19B |
| Ever Supreme Bio Technology | 14.56B |
| EirGenix | 14.01B |
| Gongwin Biopharm Holdings | 12.17B |